2601 – 2610 of 3831
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
G Protein-Coupled Receptor 39 Deficiency Is Associated with Pancreatic Islet Dysfunction
(
- Contribution to journal › Article
-
Mark
Bis- and tris(pyridyl)amine-oxidovanadium complexes: characteristics and insulin-mimetic potential.
(
- Contribution to journal › Article
-
Mark
The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men
(
- Contribution to journal › Article
-
Mark
Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy
(
- Contribution to journal › Article
-
Mark
Differential reduction in incretin hormone response to different macronutrients in obese vs lean healthy subjects
2009) 45th Annual Meeting of the European-Association-for-the-Study-of-Diabetes In Diabetologia 52(Suppl 1). p.568-568(
- Contribution to journal › Published meeting abstract
-
Mark
The Aldose Reductase Inhibitor Fidarestat Suppresses Ischemia-Reperfusion-Induced Inflammatory Response in Rat Retina.
(
- Contribution to journal › Article
-
Mark
Disruption of TFB1M impairs insulin secretion in beta cells
2009) 45th Annual Meeting of the European-Association-for-the-Study-of-Diabetes In Diabetologia 52(Suppl 1). p.116-116(
- Contribution to journal › Published meeting abstract
-
Mark
Perilipin is present in islets of Langerhans and protects against lipotoxicity when overexpressed in the beta-cell line INS-1.
(
- Contribution to journal › Article
-
Mark
Hyperactivity in adrenergic signalling via alpha2A receptors contributes to human type 2 diabetes
2009) 45th Annual Meeting of the European-Association-for-the-Study-of-Diabetes In Diabetologia 52(Suppl 1). p.108-108(
- Contribution to journal › Published meeting abstract
-
Mark
Clinical Risk Factors, DNA Variants, and the Development of Type 2 Diabetes THE AUTHORS REPLY
(
- Contribution to journal › Letter